The balance sheet has strengthened materially, with equity expanding 31% from $14.3B to $18.7B and D/E compressing to 0.89, though goodwill of $17.4B against $52.5B in total assets leaves Sentinel impairment exposure that headline leverage metrics may not reflect.
Northrop Grumman Corporation (NOC) balance sheet — 30-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 16.98B | 15.1B | 14.09B | 13.5B | 12.31B | 12.24B | 15.13B | 10.57B | 9.68B | 16.59B | 6.86B | 6.33B | 8.18B | 9.49B | 8.39B | 7.75B | 9.9B | 8.63B | 7.19B | 6.77B | 6.72B | 7.55B | 6.85B | 5.75B | 15.84B | 4.59B | 2.53B | 2.79B | 3.03B | 2.94B | 2.6B |
| Cash & Short-Term Investments | 3.74B | 4.4B | 4.35B | 3.11B | 2.58B | 3.53B | 4.91B | 2.25B | 1.58B | 11.22B | 2.54B | 2.32B | 3.86B | 5.15B | 3.86B | 3B | 3.7B | 3.27B | 1.5B | 963M | 1.01B | 1.6B | 1.23B | 342M | 1.41B | 464M | 319M | 142M | 44M | 63M | 44M |
| Cash Only | 3.74B | 4.4B | 4.35B | 3.11B | 2.58B | 3.53B | 4.91B | 2.25B | 1.58B | 11.22B | 2.54B | 2.32B | 3.86B | 5.15B | 3.86B | 3B | 3.7B | 3.27B | 1.5B | 963M | 1.01B | 1.6B | 1.23B | 342M | 1.41B | 464M | 319M | 142M | 44M | 63M | 44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 9.98B | 8.84B | 7.7B | 8.65B | 7.49B | 6.96B | 6.64B | 6.66B | 6.47B | 4.52B | 3.3B | 2.84B | 2.81B | 2.69B | 2.86B | 2.96B | 4.06B | 3.39B | 3.9B | 3.81B | 3.56B | 3.55B | 3.49B | 3.23B | 2.89B | 2.64B | 1.56B | 1.4B | 1.51B | 1.44B | 1.36B |
| Days Sales Outstanding | 82.79 | 76.93 | 68.47 | 80.33 | 74.73 | 71.22 | 65.87 | 71.83 | 78.52 | 63.92 | 49.13 | 44.08 | 42.71 | 39.74 | 41.37 | 40.96 | 52.62 | 36.7 | 42.05 | 43.47 | 43.12 | 42.21 | 42.7 | 44.93 | 61.29 | 71.15 | 74.6 | 56.89 | 61.79 | 57.46 | 61.32 |
| Inventory | 1.36B | 1.31B | 1.46B | 1.11B | 978M | 811M | 759M | 783M | 654M | 780M | 816M | 807M | 742M | 698M | 798M | 873M | 896M | 1.17B | 1B | 1.04B | 1.18B | 1.17B | 1.06B | 1.15B | 1.09B | 1.23B | 585M | 1.19B | 1.37B | 1.28B | 1.05B |
| Days Inventory Outstanding | 14.49 | 14.2 | 16.26 | 12.36 | 12.26 | 10.42 | 9.45 | 10.75 | 10.24 | 14.34 | 15.9 | 16.47 | 14.74 | 13.21 | 14.83 | 15.33 | 14.31 | 15.18 | 13.22 | 14.78 | 17.44 | 16.75 | 15.41 | 18.76 | 28.23 | 39.89 | 42.16 | 67.21 | 76.66 | 70.72 | 65.71 |
| Other Current Assets | 1.89B | 543M | 583M | 635M | 1.26B | 944M | 2.83B | 878M | 973M | 445M | 200M | 367M | 773M | 955M | 874M | 657M | 893M | 738M | 734M | 951M | 706M | 783M | 722M | 836M | 10.28B | 1.24B | 65M | 59M | 109M | 149M | 144M |
| Total Non-Current Assets | 35.52B | 36.28B | 35.27B | 32.84B | 31.27B | 30.15B | 29.13B | 30.4B | 27.97B | 18.57B | 18.76B | 18.12B | 18.39B | 16.89B | 18.15B | 17.66B | 17.73B | 21.62B | 23.01B | 26.6B | 25.29B | 26.66B | 26.45B | 27.26B | 26.43B | 16.3B | 7.1B | 6.49B | 6.5B | 6.74B | 6.83B |
| Property, Plant & Equipment | 12.64B | 12.83B | 12.31B | 11.47B | 10.61B | 9.55B | 8.6B | 8.42B | 6.37B | 4.22B | 3.59B | 3.06B | 2.99B | 2.81B | 2.89B | 3.05B | 3.04B | 4.87B | 4.81B | 4.71B | 4.53B | 4.4B | 4.21B | 4.04B | 3.6B | 2.77B | 1.01B | 1.24B | 1.27B | 1.35B | 1.4B |
| Fixed Asset Turnover | 3.50x | 3.27x | 3.33x | 3.43x | 3.45x | 3.74x | 4.28x | 4.02x | 4.72x | 6.11x | 6.83x | 7.68x | 8.02x | 8.79x | 8.74x | 8.67x | 9.24x | 6.93x | 7.05x | 6.79x | 6.65x | 6.98x | 7.09x | 6.49x | 4.77x | 4.90x | 7.51x | 7.25x | 6.99x | 6.80x | 5.76x |
| Goodwill | 17.44B | 17.44B | 17.51B | 17.52B | 17.52B | 17.52B | 17.52B | 18.71B | 18.67B | 12.46B | 12.45B | 12.46B | 12.47B | 12.44B | 12.43B | 12.37B | 12.38B | 13.52B | 947M | 17.67B | 17.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 208M | 254M | 305M | 384M | 578M | 783M | 1.04B | 1.37B | 52M | 61M | 77M | 101M | 104M | 137M | 155M | 192M | 873M | 14.52B | 1.07B | 1.14B | 18.66B | 18.66B | 19.04B | 18.21B | 9.81B | 4.43B | 3.47B | 4.18B | 4.32B | 4.42B |
| Long-Term Investments | 975M | 483M | 347M | 339M | 332M | 418M | 377M | 364M | 319M | 352M | 330M | 0 | 0 | 310M | 261M | 153M | 320M | 300M | 0 | 0 | 0 | -595M | 0 | -509M | 0 | -344M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 4.95B | 4.27B | 3.25B | 2.19B | 2.26B | 1.89B | 1.53B | 1.36B | 1.14B | 1.06B | 928M | 1.19B | 1.31B | 1.13B | 1.03B | 1.04B | 1.08B | 1.05B | 2.73B | 3.14B | 2.4B | 3.6B | 3.56B | 4.18B | 4.44B | 3.72B | 1.65B | 1.78B | 1.05B | 1.08B | 999M |
| Total Assets | 52.5B | 51.38B | 49.36B | 46.54B | 43.76B | 42.58B | 44.47B | 41.09B | 37.65B | 34.92B | 25.61B | 24.45B | 26.57B | 26.38B | 26.54B | 25.41B | 31.53B | 30.25B | 30.2B | 33.37B | 32.01B | 34.21B | 33.36B | 33.01B | 42.27B | 20.89B | 9.62B | 9.29B | 9.54B | 9.68B | 9.42B |
| Asset Turnover | 0.85x | 0.82x | 0.83x | 0.84x | 0.84x | 0.84x | 0.83x | 0.82x | 0.80x | 0.74x | 0.96x | 0.96x | 0.90x | 0.93x | 0.95x | 1.04x | 0.89x | 1.12x | 1.12x | 0.96x | 0.94x | 0.90x | 0.89x | 0.79x | 0.41x | 0.65x | 0.79x | 0.97x | 0.93x | 0.95x | 0.86x |
| Asset Growth % | 16.4% | 4.09% | 6.05% | 6.37% | 2.76% | -4.25% | 8.23% | 9.13% | 7.84% | 36.32% | 4.74% | -7.97% | 0.72% | -0.61% | 4.45% | -19.41% | 4.23% | 0.18% | -9.52% | 4.26% | -6.44% | 2.56% | 1.07% | -21.9% | 102.37% | 117.07% | 3.63% | -2.63% | -1.46% | 2.71% | 72.72% |
| Total Current Liabilities | 13.75B | 13.88B | 14.13B | 11.94B | 11.59B | 9.53B | 9.58B | 9.43B | 8.27B | 6.96B | 5.63B | 5.46B | 5.89B | 5.82B | 6.06B | 6.13B | 10.03B | 6.99B | 7.42B | 6.43B | 6.75B | 7.97B | 6.22B | 6.36B | 11.37B | 5.13B | 2.69B | 2.46B | 2.37B | 2.71B | 2.6B |
| Accounts Payable | 3.28B | 3.24B | 2.6B | 2.11B | 2.59B | 2.2B | 1.81B | 2.23B | 2.18B | 1.66B | 1.55B | 1.28B | 1.3B | 1.23B | 1.39B | 1.48B | 1.85B | 1.92B | 1.94B | 1.9B | 1.68B | 1.59B | 1.75B | 1.51B | 1.43B | 982M | 564M | 490M | 416M | 463M | 477M |
| Days Payables Outstanding | 31.66 | 35.15 | 29.04 | 23.52 | 32.42 | 28.24 | 22.48 | 30.57 | 34.18 | 30.54 | 30.28 | 26.16 | 25.92 | 23.26 | 25.87 | 26.01 | 29.49 | 24.93 | 25.6 | 26.89 | 24.9 | 22.66 | 25.41 | 24.76 | 36.93 | 31.95 | 40.64 | 27.67 | 23.23 | 25.52 | 29.77 |
| Short-Term Debt | 0 | 865M | 1.91B | 370M | 1.37B | 290M | 1B | 1.45B | 517M | 867M | 12M | 110M | 0 | 0 | 0 | 13M | 784M | 103M | 501M | 137M | 170M | 1.26B | 42M | 471M | 225M | 458M | 10M | 225M | 269M | 291M | 428M |
| Deferred Revenue (Current) | 15.44B | 4.09B | 4.07B | 4.19B | 3.61B | 3.03B | 2.52B | 2.24B | 1.92B | 1.62B | 1.47B | 1.54B | 1.71B | 1.72B | 1.76B | 1.78B | 1.97B | 1.28B | 1.28B | 1.18B | 1.18B | 1.11B | 1.07B | 995M | 1.02B | 344M | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.59B | 3.38B | 3.28B | 3.02B | 1.96B | 2.02B | 2.25B | 1.24B | 1.98B | 3.18B | 1.25B | 1.33B | -8M | 526M | 559M | 1.67B | 2.33B | 1.73B | 1.66B | 1.65B | 1.62B | 1.71B | 2.91B | 3.38B | 8.7B | 2.87B | 2.11B | 1.75B | 1.68B | 1.96B | 1.7B |
| Current Ratio | 1.23x | 1.09x | 1.00x | 1.13x | 1.06x | 1.28x | 1.58x | 1.12x | 1.17x | 2.38x | 1.22x | 1.16x | 1.39x | 1.63x | 1.39x | 1.26x | 0.99x | 1.24x | 0.97x | 1.05x | 1.00x | 0.95x | 1.10x | 0.90x | 1.39x | 0.89x | 0.94x | 1.13x | 1.28x | 1.08x | 1.00x |
| Quick Ratio | 1.14x | 0.99x | 0.89x | 1.04x | 0.98x | 1.20x | 1.50x | 1.04x | 1.09x | 2.27x | 1.07x | 1.01x | 1.26x | 1.51x | 1.25x | 1.12x | 0.90x | 1.07x | 0.83x | 0.89x | 0.82x | 0.80x | 0.93x | 0.72x | 1.30x | 0.66x | 0.72x | 0.65x | 0.70x | 0.61x | 0.59x |
| Cash Conversion Cycle | 65.61 | 55.98 | 55.69 | 69.17 | 54.57 | 53.4 | 52.84 | 52.02 | 54.59 | 47.72 | 34.75 | 34.38 | 31.53 | 29.69 | 30.33 | 30.28 | 37.44 | 26.96 | 29.66 | 31.36 | 35.67 | 36.29 | 32.69 | 38.93 | 52.59 | 79.09 | 76.11 | 96.42 | 115.23 | 102.66 | 97.27 |
| Total Non-Current Liabilities | 20.06B | 20.82B | 19.94B | 19.81B | 16.86B | 20.12B | 24.31B | 22.84B | 21.19B | 20.9B | 14.72B | 13.47B | 13.45B | 9.95B | 10.97B | 8.94B | 7.95B | 10.58B | 10.85B | 9.25B | 8.64B | 9.41B | 10.44B | 10.85B | 16.43B | 8.24B | 3.02B | 3.56B | 4.32B | 4.34B | 4.69B |
| Long-Term Debt | 14.43B | 17.02B | 16.49B | 15.68B | 13.63B | 14.37B | 15.6B | 14.08B | 13.88B | 14.4B | 7.06B | 6.39B | 5.92B | 5.93B | 3.93B | 3.94B | 4.04B | 4.19B | 3.44B | 4.27B | 4.34B | 4.23B | 5.47B | 5.41B | 9.4B | 5.03B | 1.6B | 2B | 2.56B | 2.5B | 2.95B |
| Capital Lease Obligations | 7.83B | 1.86B | 1.8B | 1.89B | 1.82B | 1.59B | 1.34B | 1.31B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.08B | 0 | -4.87B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 132M | 490M | 0 | 0 | 108M | 1.71B | 2.4B | 2.14B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 595M | 506M | 509M | 101M | 669M | 276M | 64M | 0 | 75M | 61M |
| Other Non-Current Liabilities | 3.43B | 1.95B | 1.65B | 2.24B | 1.27B | 3.68B | 7.36B | 7.45B | 7.2B | 4.8B | 7.67B | 7.06B | 7.52B | 4.02B | 7.04B | 5B | 5.43B | 6.39B | 7.41B | 4.99B | 4.3B | 4.57B | 4.44B | 4.58B | 6.68B | 2.19B | 1.13B | 1.5B | 1.76B | 1.76B | 1.68B |
| Total Liabilities | 33.81B | 34.7B | 34.07B | 31.75B | 28.44B | 29.65B | 33.89B | 32.27B | 29.47B | 27.87B | 20.36B | 18.93B | 19.34B | 15.76B | 17.03B | 15.07B | 17.97B | 17.57B | 18.28B | 15.69B | 15.39B | 17.39B | 16.66B | 17.21B | 27.8B | 13.37B | 5.7B | 6.03B | 6.69B | 7.05B | 7.29B |
| Total Debt | 16.64B | 19.74B | 20.19B | 17.94B | 16.82B | 16.25B | 17.95B | 16.83B | 14.4B | 15.27B | 7.07B | 6.5B | 5.92B | 5.93B | 3.93B | 3.95B | 4.83B | 4.29B | 3.94B | 4.41B | 4.51B | 5.5B | 5.51B | 5.88B | 9.62B | 5.49B | 1.61B | 2.23B | 2.83B | 2.79B | 3.38B |
| Net Debt | 12.89B | 15.34B | 15.84B | 14.83B | 14.25B | 12.72B | 13.04B | 14.59B | 12.82B | 4.04B | 4.53B | 4.18B | 2.06B | 778M | 68M | 946M | 1.13B | 1.02B | 2.44B | 3.44B | 3.5B | 3.89B | 4.28B | 5.54B | 8.21B | 5.03B | 1.3B | 2.08B | 2.79B | 2.73B | 3.33B |
| Debt / Equity | 0.89x | 1.18x | 1.32x | 1.21x | 1.10x | 1.26x | 1.70x | 1.91x | 1.76x | 2.17x | 1.34x | 1.18x | 0.82x | 0.56x | 0.41x | 0.38x | 0.36x | 0.34x | 0.33x | 0.25x | 0.27x | 0.33x | 0.33x | 0.37x | 0.67x | 0.73x | 0.41x | 0.68x | 0.99x | 1.06x | 1.59x |
| Debt / EBITDA | 2.81x | 3.43x | 3.52x | 4.63x | 3.40x | 2.36x | 3.37x | 3.22x | 3.14x | 4.05x | 1.94x | 1.83x | 1.62x | 1.64x | 1.08x | 1.03x | 1.43x | 1.40x | 6.07x | 1.18x | 1.43x | 1.87x | 2.00x | 2.71x | 5.02x | 3.33x | 1.09x | 1.64x | 2.46x | 2.15x | 3.30x |
| Net Debt / EBITDA | 2.18x | 2.67x | 2.76x | 3.83x | 2.88x | 1.85x | 2.45x | 2.79x | 2.80x | 1.07x | 1.24x | 1.18x | 0.56x | 0.22x | 0.02x | 0.25x | 0.33x | 0.33x | 3.75x | 0.92x | 1.11x | 1.33x | 1.55x | 2.55x | 4.29x | 3.05x | 0.88x | 1.53x | 2.43x | 2.10x | 3.25x |
| Interest Coverage | 8.98x | 8.62x | 8.81x | 5.30x | 12.53x | 13.48x | 7.29x | 5.62x | 7.66x | 12.37x | 9.91x | 10.22x | 11.33x | 12.15x | 14.99x | 14.95x | 9.80x | 9.06x | -0.76x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 18.68B | 16.67B | 15.29B | 14.79B | 15.31B | 12.93B | 10.58B | 8.82B | 8.19B | 7.05B | 5.26B | 5.52B | 7.24B | 10.62B | 9.51B | 10.34B | 13.56B | 12.69B | 11.92B | 17.69B | 16.61B | 16.83B | 16.7B | 15.8B | 14.46B | 7.51B | 3.92B | 3.26B | 2.85B | 2.62B | 2.13B |
| Equity Growth % | 55.73% | 9.05% | 3.35% | -3.38% | 18.46% | 22.19% | 19.96% | 7.72% | 16.16% | 34.02% | -4.76% | -23.68% | -31.87% | 11.63% | -7.95% | -23.76% | 6.86% | 6.43% | -32.61% | 6.45% | -1.27% | 0.77% | 5.71% | 9.25% | 92.48% | 91.71% | 20.33% | 14.28% | 8.65% | 23.26% | 45.85% |
| Book Value per Share | 131.20 | 115.95 | 103.80 | 97.34 | 98.41 | 80.34 | 63.12 | 51.88 | 46.89 | 40.14 | 29.14 | 28.82 | 34.11 | 45.40 | 37.55 | 36.70 | 45.02 | 39.24 | 35.64 | 49.92 | 46.33 | 46.33 | 45.75 | 38.66 | 63.20 | 43.53 | 27.65 | 23.33 | 20.49 | 19.27 | 16.73 |
| Total Shareholders' Equity | 18.68B | 16.67B | 15.29B | 14.79B | 15.31B | 12.93B | 10.58B | 8.82B | 8.19B | 7.05B | 5.26B | 5.52B | 7.24B | 10.62B | 9.51B | 10.34B | 13.56B | 12.69B | 11.92B | 17.69B | 16.61B | 16.83B | 16.7B | 15.79B | 14.32B | 7.39B | 3.92B | 3.26B | 2.85B | 2.62B | 2.13B |
| Common Stock | 142M | 142M | 145M | 150M | 153M | 156M | 167M | 168M | 171M | 174M | 175M | 181M | 199M | 218M | 239M | 254M | 291M | 307M | 327M | 338M | 346M | 347M | 364M | 12.43B | 12.51B | 4.45B | 1.2B | 1.03B | 0 | 0 | 0 |
| Retained Earnings | 18.61B | 16.66B | 15.3B | 14.77B | 15.31B | 12.91B | 10.48B | 8.75B | 8.07B | 11.55B | 10.63B | 10.66B | 12.39B | 12.54B | 11.14B | 9.7B | 8.24B | 6.74B | 5.59B | 7.39B | 6.18B | 5.05B | 4.01B | 3.43B | 2.87B | 3.01B | 2.74B | 2.25B | 1.89B | 1.81B | 1.35B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -132M | -126M | -152M | -128M | -153M | -143M | -128M | -97M | -52M | -4.72B | -5.55B | -5.32B | -5.36B | -2.98B | -4.79B | -3.49B | -2.76B | -3.01B | -3.64B | -699M | -1.26B | -145M | -104M | -79M | -1.06B | -71M | -23M | -19M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13M | 139M | 122M | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying NOC stock.
As of 2025, Northrop Grumman Corporation (NOC) had total assets of $51.38B including $15.10B in current assets.
Northrop Grumman Corporation (NOC) carries total debt of $19.74B, offset by $4.40B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Northrop Grumman Corporation (NOC) has total shareholders' equity (book value) of $16.67B ($115.95 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Northrop Grumman Corporation (NOC) reported a current ratio of 1.09x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Sentinel-driven goodwill impairment risk
Metrics are mathematically derived from official filings.
Deleveraging and Equity Build Underway
Northrop Grumman's balance sheet has strengthened materially over ten quarters, with equity expanding 31% from $14.3B to $18.7B while total debt declined $3.4B, compressing the debt-to-equity ratio from 1.40 to 0.89, according to the company's reported quarterly balance sheets.
The equity build appears driven almost entirely by retained earnings accumulation rather than external capital raises, suggesting the business is self-funding its deleveraging through consistent profitability. Simultaneous asset growth to $52.5B alongside falling liabilities indicates the balance sheet is expanding through retained value creation rather than leverage, though the flat goodwill line implies this asset growth is concentrated in receivables and net PPE. This trajectory, if sustained, would place NOC in a materially stronger position to absorb program execution volatility such as Sentinel cost overruns or B-21 LRIP margin compression.
Strategic Debt Reduction Reshapes Capital Structure
Total debt has been systematically reduced from $20.0B in 2024Q2 to $16.6B in 2026Q3, a 17% decline that brought the debt-to-equity ratio to 0.89, well below Lockheed Martin's 3.23 but above General Dynamics' 0.38, based on comparative financial disclosures.
The most concentrated deleveraging occurred between 2025Q4 and 2026Q3, when debt fell $3.1B—a pace that coincides with strong cumulative free cash flow of $7.55B documented in the cash flow analysis, suggesting the reduction is opportunistic rather than distress-driven. Debt-to-assets has compressed from approximately 42% to 32%, which should structurally lower interest expense and improve credit metrics going forward. Notably, buybacks have ceased during this deleveraging window, implying management may be prioritizing balance sheet resilience over shareholder returns during a period of elevated Sentinel program uncertainty.
Goodwill Dominance Masks Operating Asset Base
Goodwill of $17.4B represents roughly 33% of Northrop's $52.5B total assets, dwarfing net PPE of $12.6B, which has grown 8.6% over ten quarters, as reported in the company's quarterly balance sheet disclosures.
The asset composition reveals a business whose reported balance sheet is dominated by acquisition-derived intangibles rather than operating assets—a legacy of the Orbital ATK transaction that has remained essentially static. PPE growth to $12.6B suggests reinvestment in specialized manufacturing capacity consistent with the B-21 LRIP ramp and Sentinel infrastructure buildout, though CapEx hovering near depreciation levels indicates maintenance rather than expansion spending. The goodwill concentration means any material program impairment, particularly if Sentinel undergoes restructuring following its Nunn-McCurdy breach, could trigger a writedown that substantially erodes reported book equity.
Retained Earnings Fuel Equity as Buybacks Pause
Retained earnings have compounded from $14.3B to $18.6B over ten quarters, essentially accounting for the entire equity expansion, while buybacks halted in 2026Q2 and 2026Q3 despite $7.55B in cumulative free cash flow, according to NOC's reported balance sheets and financing disclosures.
The equity build is clean from a dilution standpoint—stock-based compensation runs at approximately $26M per quarter against $1.7B in operating cash flow, a negligible drag on per-share value. However, the cessation of buybacks after a period of consistent repurchases is analytically significant; it may suggest management is conserving capital for Sentinel-related obligations or debt retirement, or it could reflect a judgment that current valuations do not warrant aggressive repurchase. Either interpretation removes a key EPS support mechanism, shifting the earnings trajectory toward purely operational delivery and making the pending Sentinel program outcome a more consequential swing factor for per-share economics.
Current Ratio Recovery From Sub-One Trough
The current ratio recovered from a 0.94 trough in 2025Q1 to 1.23 in 2026Q3, with cash of $3.7B providing a moderate near-term buffer, though this remains a thin cushion relative to $33.8B in total liabilities, based on NOC's quarterly balance sheets.
The liquidity improvement appears driven by working capital timing rather than structural balance sheet change—cash has swung between $1.7B and $4.4B over the ten-quarter window, consistent with the milestone-driven billing pattern identified in the cash flow analysis. A current ratio of 1.23 is adequate but not robust for a contractor managing $52.5B in assets with inherently lumpy program payment cycles; a repeat of the 2025Q1 working capital consumption that drove the ratio below 1.0 could temporarily strain short-term obligations. Given a dividend commitment of roughly $1.3B annually, the liquidity buffer warrants close monitoring if defense appropriations delays or Sentinel cash flow disruptions materialize.
Goodwill Concentration Amplifies Sentinel Impairment Risk
Goodwill of $17.4B constitutes one-third of Northrop's balance sheet and is largely attributable to the Orbital ATK acquisition, yet the Sentinel program's Nunn-McCurdy cost breach introduces a credible impairment scenario that headline leverage metrics of 0.89 D/E do not reflect, per reported filings.
The most underappreciated balance sheet distortion is that reported equity of $18.7B is heavily supported by goodwill that offers no cash-generating protection against program failure. If Sentinel is restructured or its contract economics are materially renegotiated, a partial impairment could reduce book equity by a meaningful fraction, mechanically spiking leverage ratios even if operational cash generation remains intact. Additionally, the D/E of 0.89 excludes operating lease obligations and unfunded pension liabilities, which for a defense prime of this scale could add several billion dollars to the effective liability base—a factor analysts should incorporate when benchmarking against peers like General Dynamics at 0.38 D/E.